世界のブピバカイン注射市場2020-2025:0.0025、0.005、0.0075

LP Informationが発行した調査報告書(LPI21MA02172)
◆英語タイトル:Global Bupivacaine Injection Market Growth 2020-2025
◆商品コード:LPI21MA02172
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年1月(※2024年版があります。お問い合わせください。)
◆ページ数:136
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

「ブピバカイン注射の世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、0.0025、0.005、0.0075など、用途別には、病院、診療所、リカバリーセンターなどに区分してまとめた調査レポートです。ブピバカイン注射のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・ブピバカイン注射の世界市場概要(サマリー)
・ブピバカイン注射の企業別販売量・売上
・ブピバカイン注射の企業別市場シェア
・ブピバカイン注射の世界市場規模 2015年-2020年:種類別(0.0025、0.005、0.0075)
・ブピバカイン注射の世界市場規模 2015年-2020年:用途別(病院、診療所、リカバリーセンター)
・ブピバカイン注射の米州市場規模(アメリカ、カナダ、メキシコなど)
・ブピバカイン注射のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・ブピバカイン注射の欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ブピバカイン注射の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・ブピバカイン注射市場の成長要因・課題・動向
・ブピバカイン注射の世界市場予測 2021年-2025年
・ブピバカイン注射の米州市場予測(アメリカ、カナダ、メキシコなど)
・ブピバカイン注射のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・ブピバカイン注射の欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ブピバカイン注射の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・ブピバカイン注射の世界市場予測:種類別(0.0025、0.005、0.0075)
・ブピバカイン注射の世界市場予測:用途別(病院、診療所、リカバリーセンター)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Bupivacaine Injection market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Bupivacaine Injection business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Bupivacaine Injection market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Bupivacaine Injection, covering the supply chain analysis, impact assessment to the Bupivacaine Injection market size growth rate in several scenarios, and the measures to be undertaken by Bupivacaine Injection companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
0.0025
0.005
0.0075

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinics
Recovery Center

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Shandong Hualu Pharmaceutical
AuroMedics
Baxter
Areva
Fresenius Kabi
Shanghai Harvest Pharmaceutical
SteriMax
Zhaohui Pharmaceutical
AstraZeneca

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Bupivacaine Injection consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Bupivacaine Injection market by identifying its various subsegments.
Focuses on the key global Bupivacaine Injection manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Bupivacaine Injection with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Bupivacaine Injection submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bupivacaine Injection Consumption 2015-2025
2.1.2 Bupivacaine Injection Consumption CAGR by Region
2.2 Bupivacaine Injection Segment by Type
2.2.1 0.0025
2.2.2 0.005
2.2.3 0.0075
2.3 Bupivacaine Injection Consumption by Type
2.3.1 Global Bupivacaine Injection Consumption Market Share by Type (2015-2020)
2.3.2 Global Bupivacaine Injection Revenue and Market Share by Type (2015-2020)
2.3.3 Global Bupivacaine Injection Sale Price by Type (2015-2020)
2.4 Bupivacaine Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Recovery Center
2.5 Bupivacaine Injection Consumption by Application
2.5.1 Global Bupivacaine Injection Consumption Market Share by Type (2015-2020)
2.5.2 Global Bupivacaine Injection Value and Market Share by Type (2015-2020)
2.5.3 Global Bupivacaine Injection Sale Price by Type (2015-2020)

3 Global Bupivacaine Injection by Company
3.1 Global Bupivacaine Injection Sales Market Share by Company
3.1.1 Global Bupivacaine Injection Sales by Company (2018-2020)
3.1.2 Global Bupivacaine Injection Sales Market Share by Company (2018-2020)
3.2 Global Bupivacaine Injection Revenue Market Share by Company
3.2.1 Global Bupivacaine Injection Revenue by Company (2018-2020)
3.2.2 Global Bupivacaine Injection Revenue Market Share by Company (2018-2020)
3.3 Global Bupivacaine Injection Sale Price by Company
3.4 Global Bupivacaine Injection Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Bupivacaine Injection Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Bupivacaine Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Bupivacaine Injection by Regions
4.1 Bupivacaine Injection by Regions
4.2 Americas Bupivacaine Injection Consumption Growth
4.3 APAC Bupivacaine Injection Consumption Growth
4.4 Europe Bupivacaine Injection Consumption Growth
4.5 Middle East & Africa Bupivacaine Injection Consumption Growth

5 Americas
5.1 Americas Bupivacaine Injection Consumption by Countries
5.1.1 Americas Bupivacaine Injection Consumption by Countries (2015-2020)
5.1.2 Americas Bupivacaine Injection Value by Countries (2015-2020)
5.2 Americas Bupivacaine Injection Consumption by Type
5.3 Americas Bupivacaine Injection Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Bupivacaine Injection Consumption by Regions
6.1.1 APAC Bupivacaine Injection Consumption by Regions (2015-2020)
6.1.2 APAC Bupivacaine Injection Value by Regions (2015-2020)
6.2 APAC Bupivacaine Injection Consumption by Type
6.3 APAC Bupivacaine Injection Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Bupivacaine Injection by Countries
7.1.1 Europe Bupivacaine Injection Consumption by Countries (2015-2020)
7.1.2 Europe Bupivacaine Injection Value by Countries (2015-2020)
7.2 Europe Bupivacaine Injection Consumption by Type
7.3 Europe Bupivacaine Injection Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Bupivacaine Injection by Countries
8.1.1 Middle East & Africa Bupivacaine Injection Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Bupivacaine Injection Value by Countries (2015-2020)
8.2 Middle East & Africa Bupivacaine Injection Consumption by Type
8.3 Middle East & Africa Bupivacaine Injection Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Bupivacaine Injection Distributors
10.3 Bupivacaine Injection Customer

11 Global Bupivacaine Injection Market Forecast
11.1 Global Bupivacaine Injection Consumption Forecast (2021-2025)
11.2 Global Bupivacaine Injection Forecast by Regions
11.2.1 Global Bupivacaine Injection Forecast by Regions (2021-2025)
11.2.2 Global Bupivacaine Injection Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Bupivacaine Injection Forecast by Type
11.8 Global Bupivacaine Injection Forecast by Application

12 Key Players Analysis
12.1 Pfizer
12.1.1 Company Information
12.1.2 Bupivacaine Injection Product Offered
12.1.3 Pfizer Bupivacaine Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 Shandong Hualu Pharmaceutical
12.2.1 Company Information
12.2.2 Bupivacaine Injection Product Offered
12.2.3 Shandong Hualu Pharmaceutical Bupivacaine Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Shandong Hualu Pharmaceutical Latest Developments
12.3 AuroMedics
12.3.1 Company Information
12.3.2 Bupivacaine Injection Product Offered
12.3.3 AuroMedics Bupivacaine Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 AuroMedics Latest Developments
12.4 Baxter
12.4.1 Company Information
12.4.2 Bupivacaine Injection Product Offered
12.4.3 Baxter Bupivacaine Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Baxter Latest Developments
12.5 Areva
12.5.1 Company Information
12.5.2 Bupivacaine Injection Product Offered
12.5.3 Areva Bupivacaine Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Areva Latest Developments
12.6 Fresenius Kabi
12.6.1 Company Information
12.6.2 Bupivacaine Injection Product Offered
12.6.3 Fresenius Kabi Bupivacaine Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Fresenius Kabi Latest Developments
12.7 Shanghai Harvest Pharmaceutical
12.7.1 Company Information
12.7.2 Bupivacaine Injection Product Offered
12.7.3 Shanghai Harvest Pharmaceutical Bupivacaine Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Shanghai Harvest Pharmaceutical Latest Developments
12.8 SteriMax
12.8.1 Company Information
12.8.2 Bupivacaine Injection Product Offered
12.8.3 SteriMax Bupivacaine Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 SteriMax Latest Developments
12.9 Zhaohui Pharmaceutical
12.9.1 Company Information
12.9.2 Bupivacaine Injection Product Offered
12.9.3 Zhaohui Pharmaceutical Bupivacaine Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Zhaohui Pharmaceutical Latest Developments
12.10 AstraZeneca
12.10.1 Company Information
12.10.2 Bupivacaine Injection Product Offered
12.10.3 AstraZeneca Bupivacaine Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 AstraZeneca Latest Developments

13 Research Findings and Conclusion



【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のブピバカイン注射市場2020-2025:0.0025、0.005、0.0075(Global Bupivacaine Injection Market Growth 2020-2025)]についてメールでお問い合わせはこちらでお願いします。